Study: NCT01161160

Adverse event: Dengue fever
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 76 at risk

Adverse event: Cough (Days 0-41 post-vacc.)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 2 affected / 76 at risk

Adverse event: Conjunctivitis (Days 0-41 post-vacc.)
Serious: no
Organ System: Eye disorders
Frequency: 3 affected / 76 at risk

Adverse event: Pyrexia (Days 0-20 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 76 at risk

Adverse event: Pyrexia (Days 0-41 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 76 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Frequency: 41 affected / 76 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Frequency: 1 affected / 76 at risk

Adverse event: Drowsiness (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 33 at risk

Adverse event: Irritability (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 33 at risk

Adverse event: Loss of appetite (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 6 affected / 33 at risk

Adverse event: Temperature/Axillary (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 33 at risk

Adverse event: Fatigue (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 41 at risk

Adverse event: Headache (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 41 at risk

Adverse event: Joint pain (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 41 at risk

Adverse event: Muscle aches (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 6 affected / 41 at risk

Adverse event: Shivering (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 41 at risk

Adverse event: Temperature/Axillary (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 41 at risk

Adverse event: Upper respiratory tract infection (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 76 at risk

Adverse event: Nasopharyngitis (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 76 at risk

Adverse event: Rhinitis (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 4 affected / 76 at risk

Adverse event: Nasopharyngitis (Days 0-41)
Serious: no
Organ System: Infections and infestations
Frequency: 7 affected / 76 at risk

Adverse event: Upper respiratory tract infection (Days 0-41 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 6 affected / 76 at risk

Adverse event: Rhinitis (Days 0-41 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 76 at risk

Adverse event: Cough (Days 0-41 post-vacc.)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 4 affected / 75 at risk

Adverse event: Conjunctivitis (Days 0-41 post-vacc.)
Serious: no
Organ System: Eye disorders
Frequency: 1 affected / 75 at risk

Adverse event: Pyrexia (Days 0-20 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 6 affected / 75 at risk

Adverse event: Pyrexia (Days 0-41 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 9 affected / 75 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Frequency: 41 affected / 75 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Frequency: 5 affected / 75 at risk

Adverse event: Drowsiness (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 3 affected / 31 at risk

Adverse event: Irritability (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 31 at risk

Adverse event: Loss of appetite (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 31 at risk

Adverse event: Temperature/Axillary (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 31 at risk

Adverse event: Fatigue (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 3 affected / 44 at risk

Adverse event: Headache (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 9 affected / 44 at risk

Adverse event: Joint pain (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 44 at risk

Adverse event: Muscle aches (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 7 affected / 44 at risk

Adverse event: Shivering (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 44 at risk

Adverse event: Upper respiratory tract infection (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 75 at risk

Adverse event: Nasopharyngitis (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 75 at risk

Adverse event: Rhinitis (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 2 affected / 75 at risk

Adverse event: Nasopharyngitis (Days 0-41)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 75 at risk

Adverse event: Upper respiratory tract infection (Days 0-41 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 6 affected / 75 at risk

Adverse event: Rhinitis (Days 0-41 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 2 affected / 75 at risk

Adverse event: Influenza
Serious: yes
Organ System: Infections and infestations
Frequency: 1 affected / 58 at risk

Adverse event: Cough (Days 0-41 post-vacc.)
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 3 affected / 58 at risk

Adverse event: Conjunctivitis (Days 0-41 post-vacc.)
Serious: no
Organ System: Eye disorders
Frequency: 3 affected / 58 at risk

Adverse event: Pyrexia (Days 0-20 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 58 at risk

Adverse event: Pyrexia (Days 0-41 post-vacc.)
Serious: no
Organ System: General disorders
Frequency: 6 affected / 58 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Frequency: 23 affected / 58 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Frequency: 1 affected / 58 at risk

Adverse event: Drowsiness (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 24 at risk

Adverse event: Irritability (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 24 at risk

Adverse event: Loss of appetite (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 1 affected / 24 at risk

Adverse event: Temperature/Axillary (3-5Y)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 24 at risk

Adverse event: Fatigue (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 2 affected / 33 at risk

Adverse event: Headache (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 33 at risk

Adverse event: Joint pain (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 4 affected / 33 at risk

Adverse event: Muscle aches (6-10Y)
Serious: no
Organ System: General disorders
Frequency: 5 affected / 33 at risk

Adverse event: Upper respiratory tract infection (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 1 affected / 58 at risk

Adverse event: Nasopharyngitis (Days 0-20 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 2 affected / 58 at risk

Adverse event: Nasopharyngitis (Days 0-41)
Serious: no
Organ System: Infections and infestations
Frequency: 5 affected / 58 at risk

Adverse event: Upper respiratory tract infection (Days 0-41 post-vacc.)
Serious: no
Organ System: Infections and infestations
Frequency: 3 affected / 58 at risk